Veradermics reported total assets of $825.74M and total liabilities of $12.12M for the quarter ended Jun 2026. This balance sheet covers 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2024 | Mar2025 | Jun2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current Assets | ||||||
| Cash & EquivalentsCash & Equiv. | 53.08M | 21.77M | 168.41M | 319.33M | ||
| Receivables - OtherOther Receivables | 0.04M | 0.44M | 0.38M | |||
| Prepaid Assets | 2.45M | 10.63M | 6.27M | 4.85M | ||
| Current Assets | 55.53M | 152.49M | 397.07M | 824.75M | ||
| Non-Current Assets | ||||||
| Property, Plant & Equipment (Net) | 0.02M | 0.02M | 0.04M | |||
| Non-Current Assets | 0.12M | 0.29M | 0.99M | |||
| Assets | 55.53M | 152.62M | 397.36M | 825.74M | ||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payables | 2.25M | 2.13M | 1.07M | 5.92M | ||
| Payables | 2.25M | 2.13M | 1.07M | 5.92M | ||
| Accumulated Expenses | 2.47M | 6.98M | 5.61M | 5.39M | ||
| Other Accumulated Expenses | 0.05M | 0.04M | 0.38M | |||
| Total Current Liabilities | 4.72M | 9.15M | 6.72M | 11.69M | ||
| Non-Current Liabilities | ||||||
| Preferred Stock Liabilities | 66.28M | 74.71M | 74.71M | 150.56M | ||
| Operating Leases | 0.00M | 0.43M | ||||
| Total Liabilities | 4.72M | 60.67M | 76.07M | 9.16M | 6.72M | 12.12M |
| Shareholder's Equity | ||||||
| Common Equity | -48.48M | -60.67M | -76.07M | -121.01M | 390.64M | 813.61M |
| Liabilities and Shareholders Equity | 55.53M | 152.62M | 397.36M | 825.74M | ||
| Retained Earnings | -49.23M | -123.42M | 543.04M | 989.26M | ||
| Treasury Shares | 55.25M | 62.25M | 62.25M | 118.68M |